Poster

Poster

01/10/2017

Synergistic Anticancer Activity of Eribulin Plus Palbociclib in Patient-Derived Xenograft (PDX) Models of ER+/Her2- Human Breast Cancer

Synergistic Anticancer Activity of Eribulin Plus Palbociclib inPatient-Derived Xenograft (PDX) Models of ER+/Her2- Human Breast Cancer

Poster

01/10/2017

Identification by systematic in situ hybridization screen on medaka embryos of new genes as targets for anti-cancer therapy

Poster

01/04/2017

Single, low dose treatment of lymphoma and renal cancer xenografts with human anti-CD70 antibody-toxin conjugates, results in long term cures

Poster

02/01/2017

Widespread brain distribution of SGSH enzyme in canine brain following white matter injection of LYS-SAF302, an AAVrh.10-SGSH vector

Poster

02/01/2017

EORTC 2017 – “Anti tumour activity of new antibody drug conjugate (ADC) with eribulin in triple negative breast cancer (TNBC) patient-derived xenograft (PDX)”

Poster

02/01/2017

EANM 2017 – ” In vitro and in vivo evaluation of two enantiomers of Nanocyclix® EGFR targeted PET radiotracer”

Poster

02/01/2017

AACR 2017 – IMODI initiative : a novel holistic and integrative approach with patient-derived tumor models against pancreatic cancer

Poster

02/01/2017

AACR 2017 – Antitumor activity of CMP-001 (TLR9 agonist) alone or combined with immune modulators in syngeneic tumor modelsdels of brain tumors :

Poster

02/01/2017

AACR 2017 – Overcoming PD-1 targeting antibody resistance using combination strategieshuman lung tumors using DCE-MRI and FLOOD MRI

Poster

02/01/2017

AACR 2017 – Preclinical proof of concept for the first [18F]-Nanocyclix®TKI-PET radiotracer targeting activated EGFR positive lung tumors

Poster

02/01/2017

ISRS 2017 – Radiosynthesis of the first [18F]-Nanocyclix® TKI-PET radiotracer targeting activated EGFR positive lung tumors

Poster

02/01/2017

WPC 2017 – From syngeneic to humanized murine models: addressing the needs for novel immunotherapies

Scientific resource

Synergistic Anticancer Activity of Eribulin Plus Palbociclib in Patient-Derived Xenograft (PDX) Models of ER+/Her2- Human Breast Cancer

Identification by systematic in situ hybridization screen on medaka embryos of new genes as targets for anti-cancer therapy

Single, low dose treatment of lymphoma and renal cancer xenografts with human anti-CD70 antibody-toxin conjugates, results in long term cures

Widespread brain distribution of SGSH enzyme in canine brain following white matter injection of LYS-SAF302, an AAVrh.10-SGSH vector

EORTC 2017 – “Anti tumour activity of new antibody drug conjugate (ADC) with eribulin in triple negative breast cancer (TNBC) patient-derived xenograft (PDX)”

EANM 2017 – ” In vitro and in vivo evaluation of two enantiomers of Nanocyclix® EGFR targeted PET radiotracer”

AACR 2017 – IMODI initiative : a novel holistic and integrative approach with patient-derived tumor models against pancreatic cancer

AACR 2017 – Antitumor activity of CMP-001 (TLR9 agonist) alone or combined with immune modulators in syngeneic tumor modelsdels of brain tumors :

AACR 2017 – Overcoming PD-1 targeting antibody resistance using combination strategieshuman lung tumors using DCE-MRI and FLOOD MRI

AACR 2017 – Preclinical proof of concept for the first [18F]-Nanocyclix®TKI-PET radiotracer targeting activated EGFR positive lung tumors

ISRS 2017 – Radiosynthesis of the first [18F]-Nanocyclix® TKI-PET radiotracer targeting activated EGFR positive lung tumors

WPC 2017 – From syngeneic to humanized murine models: addressing the needs for novel immunotherapies

Contact-us

Science within easy reach!